• Return to Headlines

42.2% Return Seen to Date on SmarTrend Ultragenyx Pharm Call (RARE)

By Shiri Gupta

SmarTrend identified an Uptrend for Ultragenyx Pharm (NASDAQ:RARE) on April 17th, 2018 at $55.89. In approximately 2 months, Ultragenyx Pharm has returned 42.17% as of today's recent price of $79.46.

Over the past year, Ultragenyx Pharm has traded in a range of $41.67 to $91.34 and is now at $79.46, 91% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.8% while the 50-day MA has advanced 2.9%.

Ultragenyx Pharmaceutical Inc. provides biotechnology services. The Company develops therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases. Ultragenyx Pharmaceutical conducts its business in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Ultragenyx Pharm shares.

Log in and add Ultragenyx Pharm (RARE) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights ultragenyx pharm

Ticker(s): RARE